Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Prostatic Neoplasms 10 Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Cardiovascular Diseases 3 Cardiotoxicity 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Kidney Neoplasms 2 Heart Failure 2 Head and Neck Neoplasms 2 Glioblastoma 2 Endometrial Hyperplasia 2 Carcinoma, Renal Cell 2 Waldenstrom Macroglobulinemia 1 Venous Thrombosis 1 Urogenital Neoplasms 1 Smoking 1

Interventions

Dexamethasone 110 Cyclophosphamide 99 Melphalan 91 Bortezomib 68 Peripheral Blood Stem Cell Transplantation 63 Lenalidomide 57 fludarabine phosphate 55 Busulfan 53 Filgrastim 50 Antilymphocyte Serum 38 Tacrolimus 37 Thalidomide 36 Radiotherapy 36 Mycophenolic Acid 32 fludarabine 28 Cyclosporine 26 Methotrexate 25 Etoposide 22 Calcium Dobesilate 22 Prednisone 21 Whole-Body Irradiation 20 Methylprednisolone 20 sargramostim 19 pomalidomide 19 Granulocyte Colony-Stimulating Factor 18 carfilzomib 16 daratumumab 15 Cord Blood Stem Cell Transplantation 14 Carmustine 14 Rituximab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Plasma Cell × Atorvastatin × Clear all

NCT00164086 2006-10-11

Atorvastatin in Myeloma

Bayside Health

Phase 1 Unknown

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡